CAW
HAE icon

Cornerstone Advisors (Washington)’s Haemonetics HAE Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$2K Sell
20
-35
-64% -$3.06K ﹤0.01% 586
2020
Q2 		$5K Buy
55
+12
+28% +$1.21K ﹤0.01% 500
2020
Q1 		$4K Buy
43
+15
+54% +$1.63K ﹤0.01% 515
2019
Q4 		$3K Buy
28
+7
+33% +$847 ﹤0.01% 542
2019
Q3 		$3K Hold
21
– – ﹤0.01% 538
2019
Q2 		$3K Hold
21
– – ﹤0.01% 1033
2019
Q1 		$2K Buy
21
+7
+50% +$637 ﹤0.01% 1007
2018
Q4 		$1K Hold
14
– – ﹤0.01% 993
2018
Q3 		$2K Hold
14
– – ﹤0.01% 889
2018
Q2 		$1K Hold
14
– – ﹤0.01% 992
2018
Q1 		$1K Buy
+14
New +$961 ﹤0.01% 973

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cornerstone Advisors (Washington)'s HAE Position: Q3 2020 in Review

Cornerstone Advisors (Washington) reduced its Haemonetics (HAE) stake by 64% in Q3 2020, selling an estimated $3.06K and leaving 20 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #586.

Cornerstone Advisors (Washington) first reported a position in HAE in Q1 2018 and has held it in 11 quarters since. The position peaked at $5K in Q2 2020. 268 funds tracked by Wall St. Rank hold HAE as of Q3 2020.

  • Cornerstone Advisors (Washington) held 20 shares of Haemonetics worth $2K as of Q3 2020.
  • Cornerstone Advisors (Washington) sold 35 Haemonetics shares in Q3 2020, an estimated $3.06K.
  • Haemonetics made up ﹤0.01% of Cornerstone Advisors (Washington)'s portfolio in Q3 2020, its #586 holding.
  • Cornerstone Advisors (Washington) first reported a position in Haemonetics in Q1 2018 and has held it in 11 quarters since.
  • Cornerstone Advisors (Washington)'s Haemonetics position peaked at $5K in Q2 2020.
  • 268 funds tracked by Wall St. Rank held Haemonetics as of Q3 2020.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2020, filed 20 Oct 2020.